Market Research Logo

Myanmar Pharmaceutical Market - Research Report 2017-2022

Myanmar Pharmaceutical Market - Research Report 2017-2022

This report studies the Pharmaceutical market status and outlook of Myanmar, from angles of players, regions, product types and end industries; this report analyzes the top players in Myanmar and major regions, and splits the Pharmaceutical market by product type and applications/end industries.

The major players in global Pharmaceutical market include
Sun Pharmaceuticals
Cipla
Dr. Reddy¡¯s
Aristopharma
Aurobindo Pharm
SANOFI
Renata
Alkem
B Braun
SQUARE
Torrent Pharma
GSK
Beximco Pharma
Orion Pharma
Glenmark
Cadila Healthcare
Novartis
FAME
Daiichi Sankyo
Takeda
Ipca Labs
Taj Pharmaceuticals
Lupin
Kelun
Pfizer
United Pharmaceutical
BICON
Johnson &Johnson
Bayer
CSPC Pharmaceutical
Incepta Pharmaceuticals
BPI
Eli Lilly
Merck &Co.
KPC Pharmaceuticals
Opsonin Pharma
AstraZeneca
NHU
ACME
LKPC
DIL
Boehringer-Ingelheim
Holley Cotec
General Pharmaceuticals
Poly Gold
Eskayef
JIDA
ACI
ReYoung Pharmaceutical
Tensall Bio-Tech

Geographically, this report is segmented into several key Regions, revenue, market share and growth rate of Pharmaceutical in these regions, from 2012 to 2022 (forecast), covering
Lower Myanmar
Central Myanmar
North Myanmar
East Myanmar
South Myanmar
West Myanmar

On the basis of product, the Pharmaceutical market is primarily split into
Rx
OTC

On the basis on the end users/applications, this report covers
Hospital
Drugstore"


1 Pharmaceutical Market Overview
1.1 Product Overview and Scope of Pharmaceutical
1.2 Pharmaceutical Segment by Types (Product Category)
1.2.1 Myanmar Pharmaceutical Revenue and Growth Rate Comparison by Types (Product Category) (2012-2022)
1.2.2 Myanmar Pharmaceutical Revenue Market Share by Types (Product Category) in 2016
1.3 Myanmar Pharmaceutical Segment by Applications
1.3.1 Myanmar Pharmaceutical Revenue Comparison by Applications (2012-2022)
1.4 Myanmar Pharmaceutical Market by Regions/Province
1.4.1 Myanmar Pharmaceutical Revenue Comparison by Regions/Province (2012-2022)
1.4.2 South Myanmar Pharmaceutical Status and Prospect (2012-2022)
1.4.3 East Myanmar Pharmaceutical Status and Prospect (2012-2022)
1.4.4 Lower Myanmar Pharmaceutical Status and Prospect (2012-2022)
1.4.5 Central Myanmar Pharmaceutical Status and Prospect (2012-2022)
1.4.6 North Myanmar Pharmaceutical Status and Prospect (2012-2022)
1.4.7 West Myanmar Pharmaceutical Status and Prospect (2012-2022)
1.5 Myanmar Market Size of Pharmaceutical (2012-2022)
1.6 Myanmar Pharmaceutical Status and Outlook
1.7 Myanmar Pharmaceutical Sales Revenue by Therapeutic Class and Brands 2016
1.8 Myanmar Pharmaceutical Market Analysis by Company
2 Myanmar Pharmaceutical Market Competition by Players
2.1 Myanmar Pharmaceutical Revenue and Share by Players (2012-2017)
2.2 Myanmar Pharmaceutical Gross Margin by Players (2012-2017)
2.3 Players Pharmaceutical Headquarters and Establish Date
2.4 Myanmar Pharmaceutical Market Competitive Situation and Trends
3 Analysis of Myanmar Pharmaceutical Industry Key Manufacturers
3.1 Sun Pharmaceutical
3.1.1 Company Profile
3.1.2 Product Information
3.1.3 Revenue, Cost, Gross, and Gross Margin
3.2 Cipla
3.2.1 Company Profile
3.2.2 Product Information
3.2.3 Revenue, Cost, Gross, and Gross Margin
3.3 Dr. Reddy¡¯s
3.3.1 Company Profile
3.3.2 Product Information
3.3.3 Revenue, Cost, Gross, and Gross Margin
3.4 Aristopharma
3.4.1 Company Profile
3.4.2 Product Information
3.4.3 Revenue, Cost, Gross, and Gross Margin
3.5 Aurobindo Pharm
3.5.1 Company Profile
3.5.2 Product Information
3.5.3 Revenue, Cost, Gross, and Gross Margin
3.6 SANOFI
3.6.1 Company Profile
3.6.2 Product Information
3.5.3 Revenue, Cost, Gross, and Gross Margin
3.7 Renata
3.7.1 Company Profile
3.7.2 Product Information
3.7.3 Revenue, Cost, Gross, and Gross Margin
3.8 Alkem
3.8.3 Company Profile
3.8.22 Product Information
3.8.23 Revenue, Cost, Gross, and Gross Margin
3.9 B Braun
3.9.1 Company Profile
3.9.2 Product Information
3.9.3 Revenue, Cost, Gross, and Gross Margin
3.10 SQUARE
3.10.1 Company Profile
3.10.2 Product Information
3.10.3 Revenue, Cost, Gross, and Gross Margin
3.11 Torrent Pharma
3.11.1 Company Profile
3.11.2 Product Information
3.11.3 Revenue, Cost, Gross, and Gross Margin
3.12 GSK
3.12.1 Company Profile
3.12.2 Product Information
3.12.3 Revenue, Cost, Gross, and Gross Margin
3.13 Beximco Pharma
3.13.1 Company Profile
3.13.2 Product Information
3.13.3 Revenue, Cost, Gross, and Gross Margin
3.14 Orion Pharma
3.14.1 Company Profile
3.14.2 Product Information
3.14.3 Revenue, Cost, Gross, and Gross Margin
3.15 Glenmark
3.15.1 Company Profile
3.15.2 Product Information
3.15.3 Revenue, Cost, Gross, and Gross Margin
3.16 Cadila Healthcare
3.16.1 Company Profile
3.16.2 Product Information
3.16.3 Revenue, Cost, Gross, and Gross Margin
3.17 Novartis
3.13.1 Company Profile
3.13.2 Product Information
3.13.3 Revenue, Cost, Gross, and Gross Margin
3.18 FAME
3.18.1 Company Profile
3.18.2 Product Information
3.18.3 Revenue, Cost, Gross, and Gross Margin
3.19 Daiichi Sankyo
3.19.1 Company Profile
3.19.2 Product Information
3.19.3 Revenue, Cost, Gross, and Gross Margin
3.20 Takeda
3.20.1 Company Profile
3.20.2 Product Information
3.20.3 Revenue, Cost, Gross, and Gross Margin
7.21 Ipca
7.21.1 Company Profile
7.21.2 Product Information
7.21.3 Revenue, Cost, Gross, and Gross Margin
3.22 Taj Pharmaceuticals
3.22.1 Company Profile
3.22.2 Product Information
3.22.3 Revenue, Cost, Gross, and Gross Margin
3.23 Lupin
3.23.1 Company Profile
3.23.2 Product Information
3.23.3 Revenue, Cost, Gross, and Gross Margin
3.24 Kelun
3.24.1 Company Profile
3.24.2 Product Information
3.24.3 Revenue, Cost, Gross, and Gross Margin
3.25 Pfizer
3.25.1 Company Profile
3.25.2 Product Information
3.25.3 Revenue, Cost, Gross, and Gross Margin
3.26 United Pharmaceutical
3.26.1 Company Profile
3.26.2 Product Information
3.26.3 Revenue, Cost, Gross, and Gross Margin
3.27 BICON
3.27.1 Company Profile
3.27.2 Product Information
3.27.3 Revenue, Cost, Gross, and Gross Margin
3.28 Johnson &Johnson
3.28.1 Company Profile
3.28.2 Product Information
3.28.3 Revenue, Cost, Gross, and Gross Margin
3.29 Bayer
3.29.1 Company Profile
3.29.2 Product Information
3.29.3 Revenue, Cost, Gross, and Gross Margin
3.30 CSPC Pharmaceutical
3.30.1 Company Profile
3.30.2 Product Information
3.30.3 Revenue, Cost, Gross, and Gross Margin
3.31 Incepta Pharmaceuticals
3.31.1 Company Profile
3.31.2 Product Information
3.31.3 Revenue, Cost, Gross, and Gross Margin
3.32 BPI
3.32.1 Company Profile
3.32.2 Product Information
3.32.3 Revenue, Cost, Gross, and Gross Margin
3.33 Eli Lilly
3.33.1 Company Profile
3.33.2 Product Information
3.33.3 Revenue, Cost, Gross, and Gross Margin
3.34 Merck
3.34.1 Company Profile
3.34.2 Product Information
3.34.3 Revenue, Cost, Gross, and Gross Margin
3.35 KPC Pharmaceuticals
3.35.1 Company Profile
3.35.2 Product Information
3.35.3 Revenue, Cost, Gross, and Gross Margin
3.36 Opsonin Pharma
3.36.1 Company Profile
3.36.2 Product Information
3.36.3 Revenue, Cost, Gross, and Gross Margin
3.37 AstraZeneca
3.33.3 Company Profile
3.33.22 Product Information
3.33.23 Revenue, Cost, Gross, and Gross Margin
3.38 NHU
3.38.1 Company Profile
3.38.2 Product Information
3.38.3 Revenue, Cost, Gross, and Gross Margin
3.39 ACME
3.39.1 Company Profile
3.39.2 Product Information
3.39.3 Revenue, Cost, Gross, and Gross Margin
3.40 LKPC
3.40.1 Company Profile
3.40.2 Product Information
3.40.3 Revenue, Cost, Gross, and Gross Margin
3.41 DIL
3.41.1 Company Profile
3.41.2 Product Information
3.41.3 Revenue, Cost, Gross, and Gross Margin
3.42 Boehringer-Ingelheim
3.42.1 Company Profile
3.42.2 Product Information
3.42.3 Revenue, Cost, Gross, and Gross Margin
3.43 Holley Cotec
3.43.1 Company Profile
3.43.2 Product Information
3.43.3 Revenue, Cost, Gross, and Gross Margin
3.44 General Pharmaceuticals
3.44.1 Company Profile
3.44.2 Product Information
3.44.3 Revenue, Cost, Gross, and Gross Margin
3.45 Poly Gold
3.45.1 Company Profile
3.45.2 Product Information
3.45.3 Revenue, Cost, Gross, and Gross Margin
3.46 Eskayef
3.46.1 Company Profile
3.46.2 Product Information
3.46.3 Revenue, Cost, Gross, and Gross Margin
3.47 JIDA
3.47.1 Company Profile
3.47.2 Product Information
3.47.3 Revenue, Cost, Gross, and Gross Margin
3.48 ACI
3.48.1 Company Profile
3.48.2 Product Information
3.48.3 Revenue, Cost, Gross, and Gross Margin
3.49 ReYoung Pharmaceutical
3.49.1 Company Profile
3.49.2 Product Information
3.49.3 Revenue, Cost, Gross, and Gross Margin
3.50 Tensall Bio-Tech
3.50.1 Company Profile
3.50.2 Product Information
3.50.3 Revenue, Cost, Gross, and Gross Margin
4 Myanmar Pharmaceutical Market Analysis
4.1 Myanmar Pharmaceutical Revenue and Gross Margin Analysis
4.2 Myanmar Pharmaceutical Export and Import
5 Myanmar Pharmaceutical Market by Types
5.1 Myanmar Pharmaceutical Revenue and Market Share by Types (2012-2017)
5.2 Myanmar Pharmaceutical Revenue Growth by Type (2012-2017)
6 Myanmar Pharmaceutical Market by Applications
6.1 Myanmar Pharmaceutical Revenue and Market Share by Applications (2012-2017)
6.2 Myanmar Pharmaceutical Revenue Growth by Application (2012-2017)
7 Myanmar Pharmaceutical Market by Regions
7.1 Myanmar Pharmaceutical Revenue and Market Share by Regions (2012-2017)
7.2 Myanmar Pharmaceutical Revenue and Growth Rate by Region (2012-2017)
8 Pharmaceutical Manufacturing Cost Analysis
8.1 Pharmaceutical R&D Cost Analysis
8.1.1Clinical Phase Costs
8.1.2 Capitalized Costs
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Pharmaceutical
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Pharmaceutical Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Myanmar Pharmaceutical Market Forecast (2017-2022)
12.1 Myanmar Pharmaceutical Revenue Forecast (2017-2022)
12.2 Myanmar Pharmaceutical Import and Export Forecast (2017-2022)
12.3 Myanmar Pharmaceutical Revenue Forecast by Type (2017-2022)
12.4 Myanmar Pharmaceutical Revenue Forecast by Application (2017-2022)
12.5 Myanmar Pharmaceutical Revenue Forecast by Regions (Province) (2017-2022)
13 Research Findings and Conclusion
14 Methodology and Data Source
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
14.4 Author List
List of Tables and Figures
Figure Product Picture of Pharmaceutical
Figure Global Pharmaceutical Revenue (M USD) Comparison by Types (Product Category) (2012-2022)
Figure Myanmar Pharmaceutical Revenue Market Share by Types (Product Category) in 2016
Figure Global Pharmaceutical Revenue (M USD) Comparison by Applications (2012-2022)
Figure Myanmar Pharmaceutical Revenue Market Share by Applications in 2016
Figure Myanmar Pharmaceutical Revenue (M USD) Comparison by Regions (2012-2022)
Figure South Myanmar Pharmaceutical Revenue (M USD) and Growth Rate (2012-2022)
Figure East Myanmar Pharmaceutical Revenue (M USD) and Growth Rate (2012-2022)
Figure Lower Myanmar Pharmaceutical Revenue (M USD) and Growth Rate (2012-2022)
Figure Central Myanmar Pharmaceutical Revenue (M USD) and Growth Rate (2012-2022)
Figure North Myanmar Pharmaceutical Revenue (M USD) and Growth Rate (2012-2022)
Figure West Myanmar Pharmaceutical Revenue (M USD) and Growth Rate (2012-2022)
Figure Myanmar Pharmaceutical Revenue (M USD) and Growth Rate (2012-2022)
Table Myanmar Pharmaceutical Sales Revenue (M USD) by Therapeutic Class 2016
Table Myanmar Pharmaceutical Revenue (M USD) of Key Players (2016-2017)
Table Myanmar Pharmaceutical Revenue (M USD) of Key Players (2016-2017)
Table Myanmar Pharmaceutical Revenue Market Share of Key Players (2016-2017)
Table Myanmar Market Pharmaceutical Gross Margin of Key Players (2016-2017)
Table Players Pharmaceutical Headquarters and Establish Date
Figure Myanmar Pharmaceutical Revenue Market Share of Top 3 Players in 2016
Figure Myanmar Pharmaceutical Revenue Market Share of Top 5 Players in 2016
Table Sun Pharmaceutical Company Profile
Figure Myanmar Pharmaceutical Product Information of Sun Pharmaceutical
Table Myanmar Pharmaceutical Revenue (M USD), Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Sun Pharmaceutical (2016 and 2017)
Table Cipla Company Profile
Figure Myanmar Pharmaceutical Product Information of Cipla
Table Myanmar Pharmaceutical Revenue (M USD), Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin Cipla (2016 and 2017)
Table Dr. Reddy¡¯s Company Profile
Figure Myanmar Pharmaceutical Product Information of Dr. Reddy¡¯s
Table Myanmar Pharmaceutical Revenue (M USD), Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin Dr. Reddy¡¯s (2016 and 2017)
Table Aristopharma Company Profile
Figure Myanmar Pharmaceutical Product Information of Aristopharma
Table Myanmar Pharmaceutical Revenue (M USD), Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin Aristopharma (2016 and 2017)
Table Aurobindo Pharm Company Profile
Figure Myanmar Pharmaceutical Product Information of Aurobindo Pharm
Table Myanmar Pharmaceutical Revenue (M USD), Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin Aurobindo Pharm (2016 and 2017)
Table SANOFI Company Profile
Figure Myanmar Pharmaceutical Product Information of SANOFI
Table Myanmar Pharmaceutical Revenue (M USD), Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin SANOFI (2016 and 2017)
Table Renata Company Profile
Figure Myanmar Pharmaceutical Product Information of Renata
Table Myanmar Pharmaceutical Revenue (M USD), Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin Renata (2016 and 2017)
Table Alkem Company Profile
Figure Myanmar Pharmaceutical Product Information of Alkem
Table Myanmar Pharmaceutical Revenue (M USD), Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin Alkem (2016 and 2017)
Table B Braun Company Profile
Figure Myanmar Pharmaceutical Product Information of B Braun
Table Myanmar Pharmaceutical Revenue (M USD), Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin B Braun 2011-2016
Table SQUARE Company Profile
Figure Myanmar Pharmaceutical Product Information of SQUARE
Table Myanmar Pharmaceutical Revenue (M USD), Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin SQUARE (2016 and 2017)
Table Torrent Pharma Company Profile
Figure Myanmar Pharmaceutical Product Information of Torrent Pharma
Table Myanmar Pharmaceutical Revenue (M USD), Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin Torrent Pharma (2016 and 2017)
Table GSK Company Profile
Figure Myanmar Pharmaceutical Product Information of GSK
Table Myanmar Pharmaceutical Revenue (M USD), Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin GSK 2011-2016
Table Beximco Pharma Company Profile
Figure Myanmar Pharmaceutical Product Information of Beximco Pharma
Table Myanmar Pharmaceutical Revenue (M USD), Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin Beximco Pharma (2016 and 2017)
Table Orion Pharma Company Profile
Figure Myanmar Pharmaceutical Product Information of Orion Pharma
Table Myanmar Pharmaceutical Revenue (M USD), Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin Orion Pharma (2016 and 2017)
Table Glenmark Company Profile
Figure Myanmar Pharmaceutical Product Information of Glenmark
Table Myanmar Pharmaceutical Revenue (M USD), Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin Glenmark (2016 and 2017)
Table Cadila Healthcare Company Profile
Figure Myanmar Pharmaceutical Product Information of Cadila Healthcare
Table Myanmar Pharmaceutical Revenue (M USD), Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin Cadila Healthcare (2016 and 2017)
Table Novartis Company Profile
Figure Myanmar Pharmaceutical Product Information of Novartis
Table Myanmar Pharmaceutical Revenue (M USD), Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin Novartis 2011-2016
Table FAME Company Profile
Figure Myanmar Pharmaceutical Product Information of FAME
Table Myanmar Pharmaceutical Revenue (M USD), Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin FAME (2016 and 2017)
Table Daiichi Sankyo Company Profile
Figure Myanmar Pharmaceutical Product Information of Daiichi Sankyo
Table Myanmar Pharmaceutical Revenue (M USD), Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin Daiichi Sankyo (2016 and 2017)
Table Takeda Company Profile
Figure Myanmar Pharmaceutical Product Information of Takeda
Table Myanmar Pharmaceutical Revenue (M USD), Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin Takeda (2016 and 2017)
Table Ipca Company Profile
Figure Myanmar Pharmaceutical Product Information of Ipca
Table Myanmar Pharmaceutical Revenue (M USD), Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin Ipca (2016 and 2017)
Table Taj Pharmaceuticals Company Profile
Figure Myanmar Pharmaceutical Product Information of Taj Pharmaceuticals

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report